BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Genocea Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 7:54 pm Purchase | 2021-12-31 | 13G | Genocea Biosciences, Inc. GNCA | BIOTECHNOLOGY VALUE FUND L P | 5,930,353 9.990% | 644,804 (+12.20%) | Filing |
| 2021-02-12 5:03 pm Purchase | 2020-12-31 | 13G | Genocea Biosciences, Inc. GNCA | BIOTECHNOLOGY VALUE FUND L P | 5,285,549 9.990% | 2,123,881 (+67.18%) | Filing |